scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1037927M |
P356 | DOI | 10.1371/JOURNAL.PONE.0137927 |
P8608 | Fatcat ID | release_gmuuqe72sbe67c5r4jz6os2liq |
P932 | PMC publication ID | 4573979 |
P698 | PubMed publication ID | 26375394 |
P5875 | ResearchGate publication ID | 282017009 |
P50 | author | Mauro Bombaci | Q57309431 |
saveria mazzara | Q113773229 | ||
Sergio Abrignani | Q35703439 | ||
P2093 | author name string | Luigi Muratori | |
Angela Cardaci | |||
Antonia Sinisi | |||
Riccardo Lorenzo Rossi | |||
P2860 | cites work | β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma | Q24564890 |
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored | Q24607390 | ||
Autoimmune liver serology: current diagnostic and clinical challenges | Q24644140 | ||
Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. | Q50701729 | ||
Identification of new autoimmune hepatitis-specific autoantigens by using protein microarray technology. | Q51331672 | ||
Statistical pattern recognition: a review | Q56115964 | ||
PLS-regression: a basic tool of chemometrics | Q56454404 | ||
Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages | Q58622710 | ||
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group | Q80820259 | ||
Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer | Q83763225 | ||
The effect of in vivo growth hormone treatment on blood gene expression in adults with growth hormone deficiency reveals potential biomarkers to monitor growth hormone therapy | Q84767171 | ||
Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease | Q24804699 | ||
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis | Q28137622 | ||
Negative regulation of transforming growth factor-beta by the proteoglycan decorin | Q28292224 | ||
TM4 microarray software suite | Q29618829 | ||
Tumor classification by partial least squares using microarray gene expression data | Q30672243 | ||
Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach | Q30772664 | ||
Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data | Q31036404 | ||
Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens | Q33485221 | ||
Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology | Q33571853 | ||
Multivariate meta-analysis of proteomics data from human prostate and colon tumours | Q33694799 | ||
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins. | Q34020242 | ||
Primary biliary cirrhosis: What do autoantibodies tell us? | Q34041388 | ||
Rapid identification of monospecific monoclonal antibodies using a human proteome microarray | Q34151218 | ||
Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans | Q34398188 | ||
Protein microarrays and proteomics | Q35010194 | ||
Autoimmune hepatitis: a review of current diagnosis and treatment | Q35094267 | ||
A serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancers | Q35497722 | ||
Decorin-TGFβ axis in hepatic fibrosis and cirrhosis | Q35956255 | ||
Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. | Q36012754 | ||
Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays | Q36211824 | ||
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis | Q36455653 | ||
Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
Approaches to dimensionality reduction in proteomic biomarker studies | Q37098223 | ||
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments | Q37160963 | ||
Effects of rhDecorin on TGF-beta1 induced human hepatic stellate cells LX-2 activation | Q40215136 | ||
A critical assessment of feature selection methods for biomarker discovery in clinical proteomics | Q41894005 | ||
Machine learning: an indispensable tool in bioinformatics | Q42641615 | ||
Simplified criteria for the diagnosis of autoimmune hepatitis | Q44425899 | ||
Fibrinogen alpha chain O-glycopeptides as possible markers of urinary tract infection. | Q44669026 | ||
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. | Q45985033 | ||
Multi-class cancer classification via partial least squares with gene expression profiles | Q48284122 | ||
Expression of small leucine-rich proteoglycans in rat anterior pituitary gland | Q48320215 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autoimmune hepatitis | Q786844 |
biomarker | Q864574 | ||
P304 | page(s) | e0137927 | |
P577 | publication date | 2015-09-16 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis | |
P478 | volume | 10 |
Q40626404 | Accurate Quantification of Disease Markers in Human Serum Using Iron Oxide Nanoparticle-linked Immunosorbent Assay |
Q36327857 | CombiROC: an interactive web tool for selecting accurate marker combinations of omics data. |
Q38907014 | Protein microarray applications: Autoantibody detection and posttranslational modification. |
Search more.